# Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients

> **NCT05696977** · PHASE4 · UNKNOWN · sponsor: **Alexandria University** · enrollment: 74 (estimated)

## Conditions studied

- Nephrotic Syndrome

## Interventions

- **DRUG:** Cyclosporine Capsule

## Key facts

- **NCT ID:** NCT05696977
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-17
- **Primary completion:** 2024-02
- **Final completion:** 2024-04
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05696977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05696977, "Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05696977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*